Tag: PharmaNutra
Pharmanutra, distribution agreement in Canada: will sell iron-based supplements
(Finance) – PharmaNutraa company specialized in the sector of mineral-based nutritional supplements and medical devices for muscles and joints, has closed a new, important distribution contract abroad. In particular, the…
Pharmanutra, Sideral brand products start marketing in Germany
(Telestock) – PharmaNutraa company founded in 2003 by the brothers Andrea and Roberto Lacorte, specialized in the sector of mineral-based nutritional supplements and medical devices for muscles and joints, announces…
PharmaNutra, 2023 profit drops to 12.8 million. Dividend of 0.85 euros
(Finance) – PharmaNutraa company listed on Euronext STAR Milan and active in the sector of mineral supplements and medical devices for muscles and joints, closed the 2023 with Revenues from…
PharmaNutra, sales started on the American market
(Finance) – PharmaNutraa company listed on Euronext STAR Milan and active in the sector of mineral supplements and medical devices for muscles and joints, confirmed the operational start of the…
Pharmanutra achieves Lipocet classification as “novel food” in UK
(Tiper Stock Exchange) – PharmaNutra, a company specializing in the sector of mineral-based nutritional supplements and medical devices for muscles and joints, announces the acquisition of a new, important strategic…
PharmaNutra, TP ICAP Midcap confirms target price and Buy
(Finance) – TP ICAP Midcap confirmed the target price (75 euros per share) and the judgment (Buy) on PharmaNutraa company listed on Euronext STAR Milan and active in the sector…
PharmaNutra, approved the 2022 sustainability report
(Finance) – The Board of Directors of PharmaNutraa company specializing in the sector of mineral-based nutritional supplements and medical devices for muscles and joints, today approved the 2022 Sustainability Report…
Pharmanutra, new agreements signed for the foreign market
(Tiper Stock Exchange) – PharmaNutraa company specializing in the sector of nutritional supplements and medical devices for muscles and joints, announces the closing of three important new distribution contracts abroad.…
PharmaNutra: in 2022 revenues +21.5%, profit +13%
(Tiper Stock Exchange) – PharmaNutra closes the 2022 financial year with Revenues from sales consolidated in 2022 amounted to 82.7 million euros, recording a growth of 21.4% compared to the…
PharmaNutra, new commercial agreements Indonesia, Kuwait and Mexico
(Tiper Stock Exchange) – PharmaNutraa company listed on Euronext STAR Milan and active in the sector of mineral supplements and medical devices for muscles and joints, has stipulated three new…